Abdel‐Ghany A. El‐Helby

Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors

Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa et al. · Archiv der Pharmazie · 2019 · 148 citations

Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations

Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa et al. · Archiv der Pharmazie · 2019 · 111 citations

Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr et al. · Bioorganic Chemistry · 2020 · 96 citations

Molecular Docking, Medicinal Chemistry, Engineering +10

Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad et al. · Bioorganic & Medicinal Chemistry · 2020 · 91 citations · Full text

Medicinal Chemistry, Medicine, Anti-proliferative Evaluation +8

Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR‐2 Inhibitors

Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Helmy Sakr et al. · Archiv der Pharmazie · 2017 · 86 citations